Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003CLI-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01548378
Recruitment Status : Completed
First Posted : March 8, 2012
Last Update Posted : March 25, 2015
ViroMed Co., Ltd.
Information provided by (Responsible Party):
Beijing Northland Biotech. Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : June 2014